Alzex Neuropharma Inc. (TRRI)

Market Cap	452.00 -99.9%
Revenue (ttm)	4.73M +6.7%
Net Income	32.05K
EPS	n/a
Shares Out	1.51M
PE Ratio	0.01
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	113
Average Volume	2,132
Open	0.0003
Previous Close	0.0003
Day's Range	0.0003 - 0.0003
52-Week Range	0.0002 - 0.1980
Beta	-54.46
RSI	42.26
Earnings Date	n/a

About Alzex Neuropharma

Alzex Neuropharma Inc., a development stage biopharmaceutical company, engages in developing therapeutics for the treatment of Alzheimer's Disease and other neurological diseases. The company was formerly known as Trinity Resources Inc. and changed its name to Alzex Neuropharma Inc. in December 2022. The company was incorporated in 1971 and is headquartered in Las Vegas, Nevada.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1971
• Employees: 11
• Stock Exchange: OTCMKTS
• Ticker Symbol: TRRI

Financial Performance

In 2011, Alzex Neuropharma's revenue was $4.73 million, an increase of 23.83% compared to the previous year's $3.82 million. Earnings were $32,053, a decrease of -59.83%.